Skip to content
WeighLab
Menu
Ranked #10 · Grade B

Effecty review

Mid-market compounded pricing plus FDA-approved brand access and LegitScript verification, nationwide — value with a safety-net formulary.

Visit Effecty Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$160/mo
Tirzepatide
$240/mo
Coverage
All 50 states
Brand-name
Yes

Semaglutide · modeled / year

$1,920

Tirzepatide · modeled / year

$2,880

The Index scorecard

Effecty scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month80/100
Price Transparency86/100
Nationwide Access96/100
Formulation Options86/100
Clinical Oversight88/100
Contract Flexibility82/100

Where the value is

  • Both molecules disclosed at competitive prices with all-50 access
  • Offers FDA-approved brand-name access alongside compounded
  • LegitScript-certified pharmacy

The tradeoffs

  • Per-month cost is mid-market, not budget-tier
  • No oral/sublingual option

The bottom line

Best for: People who want competitive compounded pricing but also the option to step up to brand-name, verified and nationwide. Mid-market compounded pricing plus FDA-approved brand access and LegitScript verification, nationwide — value with a safety-net formulary.

Ranked #10 of 25 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've modeled, in Cost-Efficiency Index order.

Pricing, states and verification reflect Effecty's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Effecty's site. Not medical advice; see our disclosure.

← Back to the value leaderboard